SCHEMBL735335

SCHEMBL735335

COS(=O)(=O)O.Cc1ccc(N)cc1

nearest known ligand 0.56

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.56
TEAD4 Q15561 1/20 0.50
TDP1 Q9NUW8 6/20 0.48
ALDH1A1 P00352 4/20 0.48
POLB P06746 2/20 0.48
MAPT P10636 2/20 0.48
TSHR P16473 3/20 0.46
NT5E P21589 1/20 0.46
GAA P10253 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
RECQL P46063 1/20 0.44
CASP6 P55212 1/20 0.44
KMT2A Q03164 1/20 0.44
ELAVL1 Q15717 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CA1 P00915 4/20 0.42
CA2 P00918 4/20 0.42
CA9 Q16790 4/20 0.42
F2 P00734 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15285573 0.91 TSHR (0.54) ACHETDP1ALDH1A1MAPTTSHR
Sulfuric Acid SCHEMBL6839879 0.86 ACHE (0.68) ACHETEAD4TDP1ALDH1A1POLB
Sulfamate SCHEMBL28135386 0.84 ACHE (0.65) ACHETEAD4TDP1ALDH1A1POLB
SCHEMBL29225799 0.84 ACHE (0.65) ACHETEAD4TDP1ALDH1A1POLB
4-Aminophenol SCHEMBL7141388 0.83 ALDH1A1 (0.56) TDP1ALDH1A1MAPTTSHRNT5E
Sulfuric Acid SCHEMBL27705627 0.82 ACHE (0.62) ACHETEAD4TDP1ALDH1A1POLB
Aniline SCHEMBL19717871 0.80 TSHR (0.50) TDP1ALDH1A1TSHRNT5EMEN1
Aniline SCHEMBL3823035 0.80 TSHR (0.50) TDP1ALDH1A1TSHRNT5EMEN1
SCHEMBL11782818 0.78 TSHR (0.78) ACHETDP1ALDH1A1POLBMAPT
SCHEMBL8421197 0.78 TSHR (0.78) ACHETDP1ALDH1A1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0226427-B1 METHOD FOR SIMULTANEOUSLY INSPECTING THE QUALITY OF THE MILK SECRETED BY AN ANIMAL AND DIAGNOSING ITS KETOSIS STATE SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1991-07-17 EP claimed
EP-0226427-A2 Method for simultaneously inspecting the quality of the milk secreted by an animal and diagnosing its ketosis state SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1987-06-24 EP claimed
CN-111073866-B PQQ-sGDH mutant, polynucleotide and application thereof in glucose detection 英科隆生物技术(杭州)有限公司 2024-03-19 CN disclosed
US-10752934-B2 PQQ-sGDH mutant, polynucleotide and glucose detection biosensor LEADWAY (HK) LIMITED (CN) 2020-08-25 US disclosed
US-10725055-B1 Compounds for carbonyl sulfide/carbon disulfide/hydrogen sulfide release and methods of making and using the same UNIVERSITY OF OREGON (US) 2020-07-28 US disclosed
EP-3246402-B1 IMPROVED MUTANTS OF PYRROLOQUINOLINE QUINONE DEPENDENT SOLUBLE GLUCOSE DEHYDROGENASE ROCHE DIABETES CARE GMBH (DE) 2020-05-20 EP disclosed
CN-111073866-A PQQ-sGDH mutant, polynucleotide and application thereof in glucose detection 英科隆生物技术(杭州)有限公司 2020-04-28 CN disclosed
CN-105331591-B PQQ-sGDH mutant, polynucleotide and glucose detection device 英科隆生物技术(杭州)有限公司 2020-02-28 CN disclosed
CN-105331590-B Soluble pyrroloquinoline quinone dependent glucose dehydrogenase mutant with improved glucose specificity, polynucleotide and application thereof 英科隆生物技术(杭州)有限公司 2020-02-28 CN disclosed
EP-3521421-A1 GENETICALLY ENGINEERED PYRROLOQUINOLINE QUINONE DEPENDENT GLUCOSE DEHYDROGENASE COMPRISING AN AMINO ACID INSERTION Roche Diabetes Care GmbH (DE) 2019-08-07 EP disclosed
US-20190048052-A1 ANTI-MICROBIAL PEPTIDES AND COATINGS BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA 2019-02-14 US disclosed
WO-2002034919-A1 VARIANTS OF SOLUBLE PYRROLOQUINOLINE QUINONE-DEPENDENT GLUCOSE DEHYDROGENASE ROCHE DIAGNOSTICS GMBH (DE) 2002-05-02 WO disclosed
EP-0439585-B1 IMMOBILISATION OF LIGANDS BY RADIO-DERIVATIZED POLYMERS MAG GEORG MAYRHOFER & CO OHG (AT) 1997-10-29 EP disclosed
US-5545554-A Lactobacillus bulgaricus having decreased acid production and/or improved aroma and flavor production NESTEC S.A. (CH) 1996-08-13 US disclosed
EP-0638642-A1 Lactobacillus bulgaricus having decreased acid production and/or improved aroma and flavor production, and food composition comprising said lactobacillus bulgaricus SOCIETE DES PRODUITS NESTLE S.A. (CH) 1995-02-15 EP disclosed
US-5196478-A Polystyrene, assays EPIPHARM ALLERGIE-SERVICE GESELLSCHAFT M.B.H. (AT) 1993-03-23 US disclosed
EP-0439585-A1 IMMOBILISATION OF LIGANDS BY RADIO-DERIVATIZED POLYMERS. EPIPHARM ALLERGIE SERVICE (AT) 1991-08-07 EP disclosed
EP-0226427-B1 METHOD FOR SIMULTANEOUSLY INSPECTING THE QUALITY OF THE MILK SECRETED BY AN ANIMAL AND DIAGNOSING ITS KETOSIS STATE SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1991-07-17 EP disclosed
WO-1991002768-A1 IMMOBILISATION OF LIGANDS BY RADIO-DERIVATIZED POLYMERS EPIPHARM ALLERGIE-SERVICE GESELLSCHAFT M.B.H. (AT) 1991-03-07 WO disclosed
EP-0226427-A2 Method for simultaneously inspecting the quality of the milk secreted by an animal and diagnosing its ketosis state SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1987-06-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10725055-B1 Compounds for carbonyl sulfide/carbon disulfide/hydrogen sulfide release and methods of making and using the same CBS, SQOR, TST ACHE 807/4885TEAD4 4777/4885TDP1 3622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.